|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1725 I Street NW, Suite 900 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Steven J Kravitz |
Date | 1/20/2023 6:10:00 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees;
Nomination of Julie Rikelman to the U.S. Court of Appeals for the First Circuit;
Nomination of Bradley Garcia to the U.S. Court of Appeals for the D.C. Circuit;
Support for the continued confirmation of judges committed to civil and human rights;
Support for Supreme Court ethics reform;
Support for an investigation of recent Supreme Court leaks;
H.R. 7647, the Supreme Court Ethics, Recusal and Transparency Act of 2022, regarding judicial ethics reform for the U.S. Supreme Court.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Reproductive healthcare in federal spending bills and the presidential budget;
FY23 omnibus, the Consolidated Appropriations Act of 2023;
FY23 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies;
FY23 appropriations for Department of State, Foreign Operations, and Related Programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Nomination of Geeta Rao Gupta to serve as Ambassador-At-Large for Global Womens Issues at the Department of State;
Support for increased funding for UNFPA;
Support for increased funding for international family planning and reproductive health programs;
U.S. compliance with international treaties and legal obligations following the decision in Dobbs v. Jackson Womens Health Organization.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Reproductive Rights and Roe v. Wade;
State abortion bans and abortion access in the United States;
Administrative actions to protect and expand abortion access;
Administrative action to declare a national and public health emergency over Americans access to reproductive care following Dobbs v. Jackson Women Health Organization;
Access to abortion care for workers;
Access to information and resources for people seeking abortion care and reproductive health services;
H.R. 9254, HHS Reproductive and Sexual Health Ombuds Act of 2022, regarding the establishment of an ombuds for reproductive health in the Department of Health and Human Services;
H.R. 9247, Abortion Care Awareness Act, regarding an education campaign on abortion access;
Access to abortion, contraception, and maternity care for veterans, servicemembers, and dependents;
Interim final rule on veterans access to reproductive health services;
H.R. 7900, FY23 National Defense Authorization Act;
Access to the contraceptive coverage benefit under the Affordable Care Act;
Access to contraceptives and reproductive health care without cost-sharing for TRICARE enrollees;
Title X family planning program;
Teen Pregnancy Prevention Program;
Trump administration refusal of care rule;
Denials of and nondiscrimination in healthcare;
Rescission of the refusal of care rule;
Rules implementing Section 1557 of the Affordable Care Act;
Treatment of pregnant incarcerated people and detainees;
Maternal health outcomes and care options;
Paid family and medical leave;
LGBTQ+ rights;
H.R. 1065 and S. 1486, the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers;
H.R. 2234 and S. 1021, the EACH Act of 2021, regarding access to affordable health insurance plans that cover abortion;
H.R. 3755, H.R. 8296, S.4132, and S. 1975, the Women's Health Protection Act, regarding access to abortion care;
S. 4688, the Reproductive Freedom for All Act, regarding reproductive health decisions;
S. 4840 , the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, regarding restricting access to abortion;
Access to evidence-based medication abortion care;
H.Res. 1434, regarding access to reproductive health care by reaffirming the Food and Drug Administrations (FDA) authority to preempt state law and ensure access to reproductive health care products;
Criminalization of pregnancy outcomes or essential healthcare services;
State and local surveillance and investigations of reproductive health activities;
Healthcare data privacy;
Moderation of abortion mis-and disinformation by social media companies;
Free choice of provider in Medicaid programs;
Permanent, nationwide extension of postpartum Medicaid coverage.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Voting Rights.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Allowance of recipients of the Deferred Action for Childhood Arrivals (DACA) program to enroll in health insurance through the Affordable Care Act, Childrens Health Insurance Program, and Medicaid.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Stephanie |
Yost |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |